DSP216 BLOCKS HLA-G AND CD47 SIGNALING TOWARD IMMUNE CELLS AND REDESIGNS THE IMMUNE SUPPRESSIVE TUMOR MICROENVIRONMENT

被引：0
|
作者：
Jacob, L. J. [1 ]
Tamir, L. [2 ]
Abdeen, M. [2 ]
Huls, G. A. [1 ]
Chajut, A. [2 ]
Bremer, E. [1 ]
机构：
[1] Univ Med Ctr Groningen, Groningen, Netherlands
[2] KAHR Med, Jerusalem, Israel
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-ITOC9.18
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P01.06
引用
收藏
页码：A10 / A11
页数：2
相关论文
共 26 条
  • [21] Immune Checkpoint Co-blockade of CD47 and HLA Class I Receptors to increase CD20 Antibody-mediated Phagocytosis of Lymphoma Cells
    Zeller, T.
    Lutz, S.
    Munnich, I. A.
    Windisch, R.
    Hilger, P.
    Herold, T.
    Tahiri, N.
    Banck, J. C.
    Weigert, O.
    Moosmann, A.
    von Bergwelt-Baildon, M.
    Bruns, H.
    Wichmann, C.
    Valerius, T.
    Schewe, D. M.
    Peipp, M.
    Roesner, T.
    Humpe, A.
    Kellner, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 162 - 162
  • [22] CD8+PD-1-ILT2+ T Cells Are an Intratumoral Cytotoxic Population Selectively Inhibited by the Immune-Checkpoint HLA-G
    Dumont, Clement
    Jacquier, Alix
    Verine, Jerome
    Noel, Floriane
    Goujon, Annabelle
    Wu, Ching-Lien
    Hung, Tzu-Min
    Desgrandchamps, Francois
    Culine, Stephane
    Carosella, Edgardo D.
    Rouas-Freiss, Nathalie
    LeMaoult, Joel
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (10) : 1619 - 1632
  • [23] A CD47xCD19 Bispecific Antibody That Remodels the Tumor Microenvironment for Improved Killing and Provokes a Memory Immune Response to Cancer B Cells
    Ferlin, Walter G.
    Chauchet, Xavier
    Buatois, Vanessa
    Salgado-Pires, Susana
    Shang, Limin
    Dheilly, Elie
    Masternak, Krzysztof
    Johnson, Zoe
    DiPersio, John F.
    Ritchey, Julie
    Eissenberg, Linda
    Kosco-Vilbois, Marie H.
    Fischer, Nicolas
    BLOOD, 2016, 128 (22)
  • [24] An in-situ peptide-antibody self-assembly to block CD47 and CD24 signaling enhances macrophage-mediated phagocytosis and anti-tumor immune responses
    Zhang, Weiqi
    Zeng, Yinghua
    Xiao, Qiuqun
    Wu, Yuanyuan
    Liu, Jiale
    Wang, Haocheng
    Luo, Yuting
    Zhan, Jie
    Liao, Ning
    Cai, Yanbin
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [25] Chronic lung allograft dysfunction is associated with an early increase of circulating cytotoxic CD4+CD57+ILT2+T cells, selectively inhibited by the immune check-point HLA-G
    Brugiere, Olivier
    Mouren, Domitille
    Trichereau, Julie
    Vallee, Alexandre
    Kuzniak, Isabelle
    Hirschi, Sandrine
    Renaud-Picard, Benjamin
    Reynaud-Gaubert, Martine
    Nieves, Ana
    Bunel, Vincent
    Messika, Jonathan
    Demant, Xavier
    Macey, Julie
    Le Pavec, Jerome
    Dauriat, Gaelle
    Saint-Raymond, Christel
    Falque, Loic
    Mornex, Jean-Francois
    Tissot, Adrien
    Foureau, Aurore
    Krams, Aurelie Le Borgne
    Bousseau, Veronique
    Magnan, Antoine
    Picard, Clement
    Roux, Antoine
    Carosella, Edgardo
    LeMaoult, Joel
    Rouas-Freiss, Nathalie
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (05): : 626 - 640
  • [26] BND-22, a first-in-class, anti-ILT2 monoclonal antibody inhibits the immunosuppressive effects of HLA-G and enhances anti-tumor activity of immune cells in preclinical in vitro, ex vivo, and in vivo models
    Mandel, Ilana
    Haves, Dana
    Goldshtein, Ilana
    Peretz, Tsuri
    Alishekevitz, Dror
    Sapir, Yair
    Hashmueli, Sharon
    Friedman, Itay
    Ben Moshe, Tehila
    CANCER RESEARCH, 2020, 80 (16)
123